Marshall Wace Portfolio holdings
Marshall Wace is a British firm that runs long/short hedge funds. Its strategies combine computer-driven and traditional company analysis, applied worldwide and mostly to long/short equity. Paul Marshall, formerly head of European equities at Mercury Asset Management, and Ian Wace, formerly head of equities trading at Deutsche Bank, founded it in 1997. In 2002 it launched TOPS, a system that gathers investment ideas from equity professionals and uses algorithms to turn them into stock portfolios. In 2015 Marshall Wace formed a long-term partnership with KKR, a private equity and credit investor that took an ownership interest in the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3201
CEMIG Preferred Shares
CIG
$5.32B
| – | – |
-2,683,686
| Closed | -$6.41M | – |
|
3202
Chimera Investment
CIM
$697M
| – | – |
-116,565
| Closed | -$1.46M | – |
|
3203
Cincinnati Financial
CINF
$27.5B
| – | – |
-206,614
| Closed | -$32.5M | – |
|
3204
Cingulate
CING
$76.3M
| – | – |
-92,934
| Closed | -$577K | – |
|
3205
Core Laboratories
CLB
$481M
| – | – |
-117,744
| Closed | -$1.98M | – |
|
3206
Cellebrite
CLBT
$3B
| – | – |
-146,904
| Closed | -$2.02M | – |
|
3207
Cellectis
CLLS
$127M
| – | – |
-41,112
| Closed | -$130K | – |
|
3208
ClearPoint Neuro
CLPT
$322M
| – | – |
-52,259
| Closed | -$476K | – |
|
3209
Clarivate
CLVT
$1.13B
| – | – |
-1,343,271
| Closed | -$3.4M | – |
|
3210
Commercial Metals
CMC
$7.08B
| – | – |
-19,341
| Closed | -$1.19M | – |
|
3211
CALL
Comcast
CMCSA
$76.6B
| – | – |
-100
| Closed | -$2.87K | – |
|
3212
CALL
Cummins
CMI
$73.2B
| – | – |
-200
| Closed | -$108K | – |
|
3213
CALL
Centene
CNC
$33.2B
| – | – |
-24,300
| Closed | -$796K | – |
|
|
3214
PUT
Centene
CNC
$33.2B
| – | – |
-924,100
| Closed | -$30.3M | – |
|
3215
CenterPoint Energy
CNP
$27.6B
| – | – |
-152,285
| Closed | -$6.57M | – |
|
|
CNTA
3216
DELISTED
Centessa Pharmaceuticals
CNTA
| – | – |
-168,177
| Closed | -$6.68M | – |
|
3217
Z Squared Inc
ZSQR
$197M
| – | – |
-24,513
| Closed | -$275K | – |
|
3218
PUT
Coherent
COHR
$47.2B
| – | – |
-230,000
| Closed | -$54.8M | – |
|
3219
CALL
Vistance Networks Inc
VISN
$1.54B
| – | – |
-14,900
| Closed | -$271K | – |
|
3220
Chesapeake Utilities
CPK
$3.38B
| – | – |
-4,732
| Closed | -$598K | – |
|
3221
CPS Technologies
CPSH
$70.6M
| – | – |
-72,615
| Closed | -$272K | – |
|
3222
California Resources
CRC
$4.86B
| – | – |
-35,100
| Closed | -$2.43M | – |
|
3223
Crawford & Co Class B
CRD.B
$562M
| – | – |
-27,982
| Closed | -$284K | – |
|
3224
PUT
Credo Technology Group
CRDO
$32.6B
| – | – |
-210,000
| Closed | -$19.7M | – |
|
3225
Crescent Energy
CRGY
$5.81B
| – | – |
-16,390
| Closed | -$221K | – |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.